Trial Profile
Efficacy of Ofatumumab in Patients with Systemic Lupus Erythematosus who are allergic to Rituximab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2018
Price :
$35
*
At a glance
- Drugs Ofatumumab (Primary) ; Methylprednisolone
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 28 Mar 2018 New trial record
- 19 Mar 2018 Results (n=14) published in the Rheumatology.